Phase I Perifosine and Gemcitabine Study

NCT00398697 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Perifosine
DRUG: Gemcitabine

Sponsor

AEterna Zentaris